Hepcidin and iron metabolism disorders in patients with chronic kidney disease | Zendy

Marija Jelić Milutinović | Zendy; Tatjana Cvetković | Zendy; V. Djordjević | Zendy; Goran Damnjanović | Zendy; Predrag Vlahović | Zendy; Gordana Kocić | Zendy; Nataša Djindjić | Zendy; Biljana Jovovic | Zendy; Ana Antić | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hepcidin and iron metabolism disorders in patients with chronic kidney disease

Author(s) -

Marija Jelić Milutinović,

Tatjana Cvetković,

V. Djordjević,

Goran Damnjanović,

Predrag Vlahović,

Gordana Kocić,

Nataša Djindjić,

Biljana Jovovic,

Ana Antić

Publication year - 2013

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp1304368j

Subject(s) - hepcidin , transferrin saturation , ferritin , anemia , kidney disease , total iron binding capacity , medicine , serum iron , hemoglobin , endocrinology , transferrin , iron deficiency , anemia of chronic disease , dialysis , gastroenterology

[corrected] Hepcidin may play a pathogenetic role in iron metobolism disorders. The aim of this study was to determine the correlation between hepcidin concentration and parameters of iron metabolism in patients with different stage of chronic kidney disease (CKD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research